ORBIMED ADVISORS LLC 13D and 13G filings for Traws Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-05 6:55 pm Purchase | 2026-04-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 1,876,198 11.900% | 1,115,374 (+146.60%) | Filing |
| 2025-01-29 6:42 pm Purchase | 2024-12-31 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 760,824 19.900% | 155,293 (+25.65%) | Filing |
| 2024-11-06 4:12 pm Purchase | 2024-09-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 605,531 19.900% | 3,531 (+0.59%) | Filing |
| 2024-09-23 6:44 pm Purchase | 2024-09-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 602,000 19.900% | 602,000 (New Position) | Filing |